Literature DB >> 8269390

Bacillus cereus and related species.

F A Drobniewski1.   

Abstract

Bacillus cereus is a gram-positive aerobic or facultatively anaerobic spore-forming rod. It is a cause of food poisoning, which is frequently associated with the consumption of rice-based dishes. The organism produces an emetic or diarrheal syndrome induced by an emetic toxin and enterotoxin, respectively. Other toxins are produced during growth, including phospholipases, proteases, and hemolysins, one of which, cereolysin, is a thiol-activated hemolysin. These toxins may contribute to the pathogenicity of B. cereus in nongastrointestinal disease. B. cereus isolated from clinical material other than feces or vomitus was commonly dismissed as a contaminant, but increasingly it is being recognized as a species with pathogenic potential. It is now recognized as an infrequent cause of serious nongastrointestinal infection, particularly in drug addicts, the immunosuppressed, neonates, and postsurgical patients, especially when prosthetic implants such as ventricular shunts are inserted. Ocular infections are the commonest types of severe infection, including endophthalmitis, panophthalmitis, and keratitis, usually with the characteristic formation of corneal ring abscesses. Even with prompt surgical and antimicrobial agent treatment, enucleation of the eye and blindness are common sequelae. Septicemia, meningitis, endocarditis, osteomyelitis, and surgical and traumatic wound infections are other manifestations of severe disease. B. cereus produces beta-lactamases, unlike Bacillus anthracis, and so is resistant to beta-lactam antibiotics; it is usually susceptible to treatment with clindamycin, vancomycin, gentamicin, chloramphenicol, and erythromycin. Simultaneous therapy via multiple routes may be required.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269390      PMCID: PMC358292          DOI: 10.1128/CMR.6.4.324

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  144 in total

1.  Serious infections due to "non-pathogenic" organisms of the genus Bacillus. Review of their status as pathogens.

Authors:  W E FARRAR
Journal:  Am J Med       Date:  1963-01       Impact factor: 4.965

2.  Clinical spectrum of infection due to Bacillus species.

Authors:  D C Ihde; D Armstrong
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

3.  Allergic reactions of the lungs to enzymes of Bacillus subtilis.

Authors:  J Pepys; J L Longbottom; F E Hargreave; J Faux
Journal:  Lancet       Date:  1969-06-14       Impact factor: 79.321

4.  Human infections caused by organisms of the bacillus species.

Authors:  H E Pearson
Journal:  Am J Clin Pathol       Date:  1970-04       Impact factor: 2.493

Review 5.  Membrane damage by pore-forming bacterial cytolysins.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Microb Pathog       Date:  1986-02       Impact factor: 3.738

6.  Bacillus cereus enterotoxins: present status.

Authors:  R J Gilbert; J M Kramer
Journal:  Biochem Soc Trans       Date:  1984-04       Impact factor: 5.407

7.  Comparative analysis of Bacillus anthracis, Bacillus cereus, and related species on the basis of reverse transcriptase sequencing of 16S rRNA.

Authors:  C Ash; J A Farrow; M Dorsch; E Stackebrandt; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1991-07

8.  An outbreak of Bacillus cereus food poisoning resulting from contaminated vegetable sprouts.

Authors:  B L Portnoy; J M Goepfert; S M Harmon
Journal:  Am J Epidemiol       Date:  1976-06       Impact factor: 4.897

9.  Bacillus cereus panophthalmitis associated with intraocular gas bubble.

Authors:  A al-Hemidan; K A Byrne-Rhodes; K F Tabbara
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

10.  Bacillus cereus endocarditis involving a prosthetic valve.

Authors:  H A Oster; T Q Kong
Journal:  South Med J       Date:  1982-04       Impact factor: 0.954

View more
  182 in total

1.  Homoduplex and heteroduplex polymorphisms of the amplified ribosomal 16S-23S internal transcribed spacers describe genetic relationships in the "Bacillus cereus group".

Authors:  D Daffonchio; A Cherif; S Borin
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

2.  Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.

Authors:  Jean-Didier Cavallo; Francoise Ramisse; Monique Girardet; Josée Vaissaire; Michelle Mock; Eric Hernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Properties of Bacillus cereus hemolysin II: a heptameric transmembrane pore.

Authors:  George Miles; Hagan Bayley; Stephen Cheley
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

4.  A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group.

Authors:  Leyla Slamti; Didier Lereclus
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

5.  Native valve Bacillus cereus endocarditis in a non-intravenous-drug-abusing patient.

Authors:  Benjamin S Thomas; Matthew J Bankowski; William K K Lau
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

6.  Monoclonal antibodies neutralize Bacillus cereus Nhe enterotoxin by inhibiting ordered binding of its three exoprotein components.

Authors:  Andrea Didier; Richard Dietrich; Stephanie Gruber; Stefanie Bock; Maximilian Moravek; Tadashi Nakamura; Toril Lindbäck; Per Einar Granum; Erwin Märtlbauer
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

Review 7.  Immunotoxicology of arc welding fume: worker and experimental animal studies.

Authors:  Patti C Zeidler-Erdely; Aaron Erdely; James M Antonini
Journal:  J Immunotoxicol       Date:  2012-06-26       Impact factor: 3.000

8.  A novel spore protein, ExsM, regulates formation of the exosporium in Bacillus cereus and Bacillus anthracis and affects spore size and shape.

Authors:  Monica M Fazzini; Raymond Schuch; Vincent A Fischetti
Journal:  J Bacteriol       Date:  2010-06-11       Impact factor: 3.490

9.  Purification and characterization of [Formula: see text]-mannanase from Bacillus pumilus (M27) and its applications in some fruit juices.

Authors:  Ahmet Adiguzel; Hayrunnisa Nadaroglu; Gulsah Adiguzel
Journal:  J Food Sci Technol       Date:  2014-11-01       Impact factor: 2.701

10.  Analysis of the role of RsbV, RsbW, and RsbY in regulating {sigma}B activity in Bacillus cereus.

Authors:  Willem van Schaik; Marcel H Tempelaars; Marcel H Zwietering; Willem M de Vos; Tjakko Abee
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.